2026 data ClinicalTrials.gov official source

Conditions: M

Compiled by PlainTrial · January 1, 2026

Every condition beginning with M that has a registered US clinical trial, with how many studies cover each.

2,114 conditions starting with "M"

Showing 2,001–2,050 of 2,114

Condition	Trials	Recruiting
Myelofibrosis, Primary	1	1
Myelofibrosis; Anemia	2	2
Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis	1	1
Myelogenous Leukemia	1	-
Myelogenous Leukemia, Acute	1	-
Myelogenous Leukemia, Acute, Childhood	1	-
Myelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, Acute	1	-
Myeloid and Monocytic Leukemia	1	-
Myeloid Chimerism	1	1
Myeloid Diseases	2	-
Myeloid Hematological Malignancies	1	-
Myeloid Leukemia	7	4
Myeloid Leukemia Associated With Down Syndrome	4	2
Myeloid Leukemia in Relapse (Disorder)	1	1
Myeloid Leukemia, Acute	4	3
Myeloid Leukemia, Philadelphia Positive	1	1
Myeloid Leukemias	1	-
Myeloid Malignancies	6	4
Myeloid Malignancy	8	7
Myeloid Metaplasia	2	-
Myeloid Neoplasm	8	4
Myeloid Neoplasm Post Cytotoxic Therapy	1	1
Myeloid Proliferations Associated With Down Syndrome	1	-
Myeloid Sarcoma	4	2
Myelokathexis	1	1
Myeloma	30	10
Myeloma Multiple	8	3
Myeloma, Plasma Cell	3	-
Myelomatosis	2	-
Myelomeningocele	9	5
Myelomonocytic Leukemia, Chronic	1	-
Myelopathy Cervical	1	-
Myelopathy, Compressive	1	1
Myeloproliferative Chronic Myelomonocytic Leukemia	1	1
Myeloproliferative Disorder	4	1
Myeloproliferative Disorders	9	5
Myeloproliferative Neoplasm	41	20
Myeloproliferative Neoplasm (MPN)	1	1
Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis	1	1
Myeloproliferative Neoplasm, Not Otherwise Specified	2	2
Myeloproliferative Neoplasms	9	6
Myeloproliferative Neoplasms (MPNs)	1	-
Myeloproliferative Neoplasms of	1	-
Myeloproliferative Syndrome	2	2
Myeloschisis	2	1
Myeodysplastic Syndrome	1	1
Myo Munchee	1	1
Myocardial Blood Flow	1	1
Myocardial Bridge of Coronary Artery	1	1
Myocardial Deformation	1	-

Browse all → | Rankings →

Data sourced from official public datasets. See our methodology for details.

Related